Press Releases - Emmaus Medical, Inc.

Emmaus Life Sciences Reports 2022 Financial Results and Provides Business UpdateMarch 31, 2023

Emmaus Life Sciences, Inc. (OTCQX: EMMA), today reported its results of operation for the year ended December 31, 2022 and an update on recent activities.

Dr. Niihara Meets with Local Indian GovernorDecember 20, 2022

Cites Large, Unserved Needs of Sickle Cell Disease Patient

Dr. Niihara Feted by Indian Government in Recognition of the Development of EndariDecember 19, 2022

Emmaus Life Sciences, Inc. announced today that Dr. Yutaka Niihara, Chairman and Chief Executive Officer of the company, was feted at an event held on December 16, 2022 at the World Trade Center in Mumbai, India by the Minister of State of India, Arun Halder, in recognition of Dr. Niihara’s work in developing Endari to treat sickle cell disease (SCD).

Endari Receives Kuwaiti Marketing AuthorizationDecember 07, 2022

Kuwait is Third Gulf Cooperation Council Country to Approve Endari

Emmaus Life Sciences Receives Endari Marketing Authorization from the Qatar Ministry of Public HealthNovember 17, 2022

Emmaus Life Sciences, Inc.announced today that it has been issued a Registration Certificate from the Registration Committee for Pharmaceutical Companies & their Products of the Qatar Ministry of Public Health granting marketing authorization for the commercial distribution and sale of Endari in the country.